div style=”text-align: justify;”Oppenheimer is out downgradingspan style=”font-weight: bold;” Apple (NASDAQ:AAPL)/span to Market Perform from Outperform span style=”color: rgb(255, 0, 0); font-weight: bold;”saying they don’t know why Steve Jobs has pulled out of his annual address at Macworld on January 6. Maybe he’s not feeling well, or maybe he just has nothing new to say/spanspan style=”font-weight: bold;”./span Whatever the reason, the unexpected announcement has underscored the greatest risk to Apple’s long-term success—its dependence on Jobs’ health and its apparent lack of a succession plan.br /br /Six months have passed since Jobs appeared at the Apple Developer Conference, looking drawn and unwell. It’s past time for Apple to either disclose the state of his health or elaborate a viable plan for eventually transferring power. Until such time, they can no longer continue to recommend Apple as a long-term investment. Downgrading to Perform; and removing $145 PT.br /br /span style=”color: rgb(255, 0, 0);”Notablecalls:/span This call I think will generate some serious debate about Jobs’ health. It sure takes a set of cojones to come out with a downgrade like this one.br /br /I see more downside to AAPL stock in the n-t./div

Last 5 posts by Notable Calls

• Petroquest Energy (NYSE:PQ): Compelling Valuation with Near-Term Catalysts; Upgrading to Overweight - J.P. Morgan - October 29th, 2009
• 15% correction coming in SP500? - October 21st, 2009
• Boeing (NYSE:BA): Downgraded to Underweight at Morgan Stanley, target to $43 - October 20th, 2009
• Par Pharmaceuticals (NYSE:PRX): Upgraded to Overweight at Barclays; target raised to $30 - October 15th, 2009
• Wyndham Worldwide (NYSE:WYN): Upgraded to Buy at Goldman Sachs; $26 target established - October 7th, 2009